Literature DB >> 13502840

The fluorometric measurement of the absorption, distribution and excretion of single doses of 4-amino-10-methyl pteroylglutamic acid (amethopterin) in man.

M V FREEMAN.   

Abstract

Entities:  

Keywords:  FOLIC ACID ANTAGONISTS/metabolism

Mesh：

Substances：

Year:  1958        PMID： 13502840

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  11 in total

1.  The metabolism of tritiated folic acid in man.

Authors:  D G JOHNS; S SPERTI; A S BURGEN
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

Review 2.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

3.  [Effect and istribution of methotrexate in the human organism during leukemia treatment].

Authors:  W Wilmanns; H Martin
Journal:  Klin Wochenschr       Date:  1968-03-15

4.  The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle.

Authors:  V J Harvey; M L Slevin; R C Woollard; A Johnston; M J Barnett; P F Wrigley; P Turner
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Renal function and the rate of disappearance of methotrexate from serum.

Authors:  L O Kristensen; K Weismann; L Hutters
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

6.  [The eye in leukemia].

Authors:  P Brégeat
Journal:  Doc Ophthalmol       Date:  1966       Impact factor: 2.379

Review 7.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

8.  Clinical pharmacology of intermediate-dose oral methotrexate.

Authors:  D K Smith; G A Omura; F Ostroy
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

9.  7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

Authors:  S A Jacobs; R G Stoller; B A Chabner; D G Johns
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

10.  Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats.

Authors:  Kenji Takeuchi; Masakazu Shibata; Eiji Kashiyama; Ken Umehara
Journal:  Exp Ther Med       Date:  2012-06-29       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.